APA
Kereiakes D. J., Sudhir K., Hermiller J. B., Gordon P. C., Ferguson J., Yaqub M., Sood P., Su X., Yakubov S., Lansky A. J. & Stone G. W. (20110509). Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials. : JACC. Cardiovascular interventions.
Chicago
Kereiakes Dean J, Sudhir Krishnankutty, Hermiller James B, Gordon Paul C, Ferguson Joanne, Yaqub Manejeh, Sood Poornima, Su Xiaolu, Yakubov Steven, Lansky Alexandra J and Stone Gregg W. 20110509. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials. : JACC. Cardiovascular interventions.
Harvard
Kereiakes D. J., Sudhir K., Hermiller J. B., Gordon P. C., Ferguson J., Yaqub M., Sood P., Su X., Yakubov S., Lansky A. J. and Stone G. W. (20110509). Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials. : JACC. Cardiovascular interventions.
MLA
Kereiakes Dean J, Sudhir Krishnankutty, Hermiller James B, Gordon Paul C, Ferguson Joanne, Yaqub Manejeh, Sood Poornima, Su Xiaolu, Yakubov Steven, Lansky Alexandra J and Stone Gregg W. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials. : JACC. Cardiovascular interventions. 20110509.